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Abstract
Staphylococcus sp. is not only a commensal bacterium but also a major human pathogen
that causes a wide range of clinical infections, such as skin and soft tissue infection,
pleuropulmonary and osteoarticular infection, and endocarditis as well as life-
threatening systemic infections. More evidence is currently emerging to show that
Staphylococcus, particularly Staphylococcus aureus, can colonize the reproductive
systems and affect their structure and function. Staphylococcal infection has become
one of the most common causes of infertility in both males and females. This chapter
focuses on the epidemiology, pathophysiology, clinical manifestations, and treatment
of staphylococcal infection and infertility.
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1. Introduction
Bacterial infection in reproductive organs is one of the most common causes of infertility in
both male and female patients. It is also associated with sexually transmitted infections and
adverse pregnancy outcomes. Infection with different microorganisms, such as chlamydia,
mycoplasma, and certain bacteria, may lead to various clinical manifestations of human
reproductive function. Staphylococcus sp., although a commensal bacterium, is a leading cause
of skin and soft tissue infections and life-threatening systemic infections. More evidence is
currently emerging to support the vaginal colonization of Staphylococcus sp. and its involve‐
ment in heterosexual transmission and infertility, but the knowledge is relatively scarce. In
this chapter, genital staphylococcal infection and its relationship with infertility are discussed
in detail.
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
2. Overview of staphylococcal infection
2.1. The staphylococci
Bacteria in the genus Staphylococcus are referred to Gram-positive spherical bacteria that widely
affect man and other mammals. The bacteria are about 0.5–1.0 μm in diameter and grow in
clusters, pairs, and occasionally in short chains. Staphylococci are divided into two groups
based on their ability to clot blood plasma. The coagulase-positive staphylococci constitute the
most pathogenic species Staphylococcus aureus. The coagulase-negative staphylococci (CNS)
comprise over 30 other species, most of which are commensals of skin without causing
infections. However, the incidence of infections of Staphylococcus epidermidisand other CNS has
currently been rising. Among the known staphylococci, S. aureus is the most important human
pathogen and causes a wide range of clinical infections [1]. It colonizes mainly the nasal
passages, but also the other anatomical locales, such as skin, oral cavity, and gastrointestinal
tract. Critically, S. aureus has been proved to be one of the most prevalent organisms in male
and female genital tract, and its implication in the pathogenesis of reproductive diseases and
infertility has attracted increasing attention [2]. In addition, the CNS stains such as S. epider‐
midis and Staphylococcus haemolyticus are also listed as the bacteria that can occupy and
associated with male infertility.
2.2. The pathogenesis of Staphylococcus aureus
S. aureus is the leading cause of bacterial infections affecting an enormous population world‐
wide. By invading the bloodstream, lower respiratory tract, and skin and soft tissue, S.
aureus can potentially cause some of the most severe hospital-associated and community-
acquired illnesses. S. aureus produces a myriad of virulence factors that allow the organism to
gain entry into tissues, attach to host cells, and secret exoproteins and toxins. The known
virulence factors include lipoteichioic acid (LTA), toxic shock syndrome toxin-1 (TSST-1),
staphylococcal enterotoxin A (SEA), and staphylococcal enterotoxin B. In addition, S. aureus
expresses a cohort of special factors that indirectly exert pathogenic effects through interfering
with host defense mechanisms. This category involves capsular polysaccharide, protein A, and
leukocidin. The classical Panton and Valentine (PV) leukocidin is considered as a contributing
factor for necrotizing skin infections due to its leukotoxic activity [3]. Recently, a novel strategy
was invented whereby S. aureus successfully escapes neutrophil-mediated defensive machi‐
nery and establishes its invasion and infection. In this case, S. aureus secretes the nuclease and
adenosine synthase to convert neutrophil extracellular traps (NETs) to deoxyadenosine, which
triggers the caspase-3-triggered death of immune cells [4].
2.3. The host defense against staphylococcal infection
Neutrophils represent the host’s first line of defense against invasion by S. aureus and a critical
determinant in the outcome of staphylococcal infections. Following the uptake of bacteria,
neutrophils typically undergo accelerated apoptosis and are cleared by macrophages through
efferocytosis. This process results in eradication of the microbe and recovery of inflammation.
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The pathogen recognition pattern receptor, toll-like receptor (TLR2), is proved to be the
dominant receptor for S. aureus. TLR2 on the surface of innate immune cells recognizes the
components of the bacterial cell wall such as teichoic acid, LTA, and PGN-embedded lipo‐
peptides [5]. TLR2 then dimerizes with either TLR1 or TLR6 and recruits the adaptor proteins,
such as TIRAP and MyD88, and the serine/threonine kinases IRAK-1 and IRAK-4 to initiate
the subsequent signaling. The signaling cascade ultimately leads to the activation of the
transcription factor nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinases
(MAPKs), which promotes the production of proinflammatory cytokines such as tumor
necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-12p70 and chemokines such as (C-C
motif) ligand (CCL)2, CCL3, and CCL4. Besides TLR2, C-type lecin receptors (CLRs) can also
bind to surface sugars of S. aureus and enhance the phagocytic ability of antigen-presenting
cells (APCs) [6]. The cytokines and chemokines released by the innate immune cells and/or
the infected tissue cells have important roles in combating infection of S. aureus. They can
recruit the innate immune cells to site of infection and activate the immune cells to phagocytose
and kill the microbes. However, the extensive infiltration of inflammatory cells and the copious
secretion of proinflammatory mediators may also cause tissue damage and immunopathology
if the inflammation is unresolved.
When innate immune mechanisms are not sufficient to clear the bacterial infection, an adaptive
immunity against S. aureus, such as T helper (Th)1 and Th17, and humoral antibody responses,
might be required [7]. The production of IL-1 and IL-17A, upon activation of Th1 or Th17 cells,
is presumably conductive to the abscess formation at site of infection. Abscessification is
regarded as a hallmark of S. aureus infections and is essential for the clearance of bacteria
through phagocytosis and oxidative burst. On the other hand, Th1 response during S. aureus
infections is frequently associated with the activity of staphylococcal superantigens (SAgs).
For example, TSS has been found to activate roughly 20% of T cells and trigger massive
proliferation of T cells and production of cytokines [8]. A strong proinflammatory/Th1
response was also ascribed to the effect of SEA, which is another staphylococcal SAg.
2.4. Clinical manifestations of staphylococcal infection
Manifestations of staphylococcal infections usually depend on the type of infection, the site,
the route, and the microbial dose. Common types of infections include skin infections (e.g.
folliculitis, furuncles, impetigo, wound infections, and scalded skin syndrome), soft-tissue
infections (e.g. pyomyositis, septic bursitis, and septic arthritis), toxic shock syndrome,
purpura fulminans, endocarditis, osteomyelitis, pneumonia, food poisoning, and urinary tract
infection [1, 9]. Despite associated with such a wide spectrum of clinical manifestations, S.
aureus is still a commensal bacterium. Approximately 30% of the human population is
colonized with this microbe [10]. However, with a growing number of health care–associated
and antibiotic-resistant strain–driven infections, the pathogenic staphylococcal infection has
significantly increased during the past two decades. In particular, the dramatic rising of
antibiotic-resistant strains has become a serious threat to public health. The term MRSA refers
to methicillin-resistant S. aureus with the potential to resist all β-lactam antibiotics such as
penicillins and cephalosporins. Resistance is usually conferred by the acquisition of a non-
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native gene encoding a penicillin-binding protein (PBP2a) that has significantly lower affinity
for β-lactams [11]. In addition to MRSA, the vancomycin-intermediate/resistant S. aureus
(VISA/VRSA) strain has also been reported in staphylococcal infection, particularly in some
cases of enterococcal infection.
3. Epidemiology of genitourinary staphylococcal infection
Barring the role of a few bacteria such as Chlamydia whose impact on fertility has been well
established, the significance of other bacteria in infertility is controversial. An epidemiological
research revealed that the prevalence of bacterial vaginosis (BV) as 70.34% among infertile
women. Previously, the categories of organisms with the potential to cause bacterial infection
in female reproductive system have involved Gardnerella vaginalis, Mobiluncus sp., Bacteroide
sp., Prevotella sp., and Mycoplasma sp. [12]. In general, Gram-positive bacteria were significantly
higher in number than the Gram-negative bacteria. Series of epidemiological studies have
revealed that Staphylococcus is among the top bacterium detected from reproductive organs
and is closely related with infertility. For example, Momoh et al. [13] reported a prevalence
rate of 38.7% S. aureus from high vaginal swab and endocervical swabs and a prevalence of
75% from semen cultures of infertile couples. Another investigation identified S. aureus as the
most prevalent vaginal pathogen (57.33%) among local infertile women, followed by Escheri‐
chia coli (25.33%) [14].
Parallel to the situation in females, abnormal presence of Staphylococcus sp. has been increas‐
ingly evidenced in the genitourinary system of male patients with fertile problem. In a study
of a total of 140 sperm samples collected from the University of Benin Teaching Hospital, S.
aureus (28.3%) and S. saprohyticus (13.0%) were the most common pathogens found and have
negative effects on sperm motility and morphology [15]. The commonest bacteria isolated from
160 men attending infertility clinics in South-eastern Nigeria were Proteus sp., S. aureus, and
E. coli, and most of the detected strains were resistant to antibiotics assessed[16]. Besides the
S. aureus, other staphylococci are also commonly found in infertile male patients. S. epidermi‐
dis was found to be one of the most common bacteria in 295 infertile males at the Hospital
Juárez de México, and the bacteria profoundly affected the sperm motility, pH, morphology,
and viscosity [17].
In healthy women of child-bearing age, the protective mucosa in the vagina is populated with
microflora typically dominated by lactobacilli, and their dominance over pathogenic anae‐
robes is positively associated with vaginal health. Thanks to the biological antagonism
provided by a healthy vaginal microbiota, opportunistic microorganisms are in very low
numbers in normal vagina. It is proven that lactobacilli provide a constant acidic pH value and
maintain the appropriate concentration of hydrogen peroxide in the genital environment.
While under the condition of BV, the concentration of lactobacilli reduces but of some
pathogenic bacteria, especially anaerobes or microaerophiles, increase [18]. BV represents the
most common vaginal syndrome that affects fertile, premenopausal, and pregnant women,
with an incidence rate ranging from 20% to 50% [19, 20]. BV is not caused by one specific
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pathogenic microorganism but rather by an imbalance of vaginal microbiota. Staphylococcus
sp., as a kind of amphimicrobian, has been established as one of the specific pathogenic bacteria
related to BV. BV is frequently disregarded because the symptoms are often absent or insig‐
nificant. However, this vaginal disorder has already become the most common lower genital
tract disorder among women of reproductive age and the most prevalent cause of vaginal
discharge and malodour.
Genitourinary MRSA carriage and infection are not rare. A retrospective study was previously
conducted on 57 pregnant women positive for MRSA over a 4.5-year period. The data showed
that skin and soft tissue infection accounted for 96% of cases and recurrent infection occurred
in 58% of the women [21]. Vaginal colonization with S. aureus and MRSA was further valuated
by Chen et al., who reported that 507 S. aureus isolates (17.1%) were obtained from vaginal
cultures of 2963 pregnant women, of which 14 (2.8%) were MRSA [22]. In addition, MRSA has
become the predominant pathogen that causes the surgically managed infections in the
genitourinary area. S. aureus, along with E. coli, Streptococci, and Trichomonas vaginalis, forms
the abnormal vaginal flora that contributes to the onset of aerobic vaginitis. These pathogenic
bacteria substantially alter the vaginal lactate concentration and increase the levels of inflam‐
matory cytokines such as IL-6, IL-1β and leukemia inhibitory factor (LIF) in the vaginal fluid.
Two methicillin-sensitive stains of S. aureus (MNPE and CDC587) have been documented to
induce the expression of IL-8 in human vaginal epithelial cells [23]. Alterations in vaginal
microbiology have been associated with many pathological conditions such as endometritis,
miscarriage, premature labor, and infertility [24]. Moreover, the flora and cytokines imbalance
has implicated in the pathogenesis of pelvic inflammatory disease (PID) and cervicitis and is
also a risk factor for urinary tract infection and sexually transmitted disease (STD) [25].
4. Staphylococcal infection and male infertility
Urogenital tract infections in males are one of the significant etiological factors in infertility.
The infection of bacteria such as Staphylococcus sp. has been detected at the male reproductive
tract. Staphylococcal infection in male reproductive organs and accessory glands may exert
detrimental effect on sperm activity. Previous studies indicated that staphylococci not only
affect the sperm activity but also impact the secretory capacity of the epididymis, seminal
vesicles, and prostate [26]. In fact, staphylococci have been identified as one of the most
common strains that can be detected in the male reproductive system. However, the percen‐
tages of males that get infected with staphylococci vary with the different isolation methods
and procedures used in different studies. It has been demonstrated that S. aureus infection
significantly interferes with semen quality and activity. It deteriorates the volume of semen
and the concentration of sperm as well as the motility, morphology, and vitality of sperm.
Therefore, a causative relationship may exist between staphylococcal infection and male
infertility. A previous study reported a 20.6% infection of S. aureus in the semen samples from
males with fertility problems. More importantly, S. aureus infection was found to be closely
related to poor semen quality and reduced sperm motility [27]. Also, an investigation by a
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Poland group associated S. aureus infection with abnormal semen parameters or other
surogenital tract infection [28].
Besides these prospective studies, several in vitro studies also support the effect of Staphylo‐
coccus on sperm activity and its relation with infertility. It was revealed that infection of the
normal human ejaculated spermatozoa with S. haemolyticus profoundly impacted the archi‐
tecture and integrity of the sperm plasma membrane. Bacterial infection serves as a contribu‐
ting factor for severe injury of sperm membrane stability and mitochondrial activity with
potential consequences of male fertility [29]. In addition, exposure of ejaculated spermatozoa
to S. haemolyticus was found to trigger a simultaneous decrease in the percentage of sperm with
normal ΔΨm and an increase in the proportion of sperm with Annexin V staining, indicative
of apoptotic cells. The data suggested a determinant role of staphylococcal infection in sperm
fate [30]. Despite the above findings, the role for staphylococci in male infertility has remained
somewhat controversial. A previous study showed that, although Staphylococcus sp. was the
most common bacteria isolated in 299 asymptomatic men undergoing fertility evaluation, the
bacterial counts were not correlated with semen parameters [31].
In an effort to understand the mechanism whereby staphylococci modulate sperm activity,
investigators currently identified some of the key molecules that have profound effect on
sperm activity. Kaur and Prabha et al. firstly identified sperm agglutinating factor (SAF). Based
on the observation that S. aureus can adhere to the sperm head as well as sperm tail and
agglutinate mouse spermatozoa, the group finally isolated a protein with a molecular weight
of approximately 57 kDa from S. aureus and implicated the protein in control of sperm motility
and survival. Moreover, SAF potentially affects various sperm parameters such as Mg2+-
dependent ATPase activity, acrosome status, and apoptosis. In support of this, a profound
morphological alteration occurs in the spermatozoa upon binding with SAF, as detected with
scanning electron microscopy. Also, SAF has a spermicidal effect at high concentrations and
may have the potential to function as active ingredient of a vaginal contraceptive. Further
studies indicate that the interaction of SAF with spermatozoa is receptor mediated, and the
receptor has been isolated and purified from human spermatozoa. This sperm surface receptor
component showed homology to glutamate decarboxylase and major histocompatibility
complex (MHC) class I molecule [32]. Intriguingly, the receptor was shown to be able to
counteract the detrimental effects of SAF on sperm parameters and alleviate SAF-induced
infertility in mice [33]. In addition, Prabha et al. isolated the SAF from an E. coli strain. This
kind of SAF also leads to sperm agglutination, the compromised Mg2+-dependent ATPase
activity, and spermatozoa apoptosis.
In 2009, another protein with sperm regulatory effect, named sperm immobilization factor
(SIF), was identified from S. aureus. SIF is a protein with the molecular weight of approximately
20 kDa. Similar to SAF, SIF causes multiple defects in the head, midpiece, neck, and tail region
of human spermatozoa [34]. It can completely inhibit Mg2+ ATPase activity of spermatozoa at
the concentration of 100 μg/ml and reduce calcium ionophore–induced acrosome reaction. The
interaction between SIF and spermatozoa is also ligand-receptor dependent. The analysis by
matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) showed that the
receptor shares sequence similarity with MHC class II antigen. Interestingly, SIF has been
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found to impede motile bacteria, in addition to sperm, such as E. coli, Pseudomonas aeruginosa,
and Proteus mirabilis. The molecular mimicry of SIF receptor has been confirmed between
spermatozoa and bacteria [35].
In addition to the effector molecules mentioned above, some novel mechanisms responsible
for the staphylococcal regulation of sperm have now been discovered. A recent study on the
semen of 589 infertile males indicated that other virulence genes in S. aureus, such as hlg
(33.3%), scn (23.3%), cna (20%), hlb (20%), and clfA (18.3%), were possibly responsible for
spermatozoal immobilization [36]. Berktas et al. raised another point of view that, rather than
the direct interaction between bacteria and sperm, the alteration in genital microenvironment
or ver-consumption of energy by high dose of bacterium led to the loss of sperm motility [37].
5. Staphylococcal infection and female infertility
Bacterial infection in female reproductive system, such as staphylococcal infection, can
profoundly affect all the phases of a woman’s life in relation to the period of pre-pregnancy,
fertilization, pregnancy, and reproduction. It has been demonstrated that BV is the most
common lower genital tract disorder among women of reproductive age. In particular,
staphylococcal infection is presumed to be a contributing factor for the adverse pregnancy
outcomes and female infertility. Staphylococcal infection causes malodorous vaginal discharge
and is causally associated with sexually transmitted infections. Also, it has been implicated in
the development of endometritis (endometriosis), another crucial factor to female infertility.
5.1. Inflammatory response and hypothalamic endocrine
An immune/inflammatory challenge is considered as an important factor that impinges the
reproduction process in animals and humans [38]. It can affect reproduction at the level of the
hypothalamus, pituitary gland, or gonads. Nonetheless, the major impact is thought to occur
within the brain or the pituitary gland [39]. Bacterial endotoxins can trigger the release of
cytokines and other immune mediators in the hypothalamus, where the luteinizing hormone
(LH)-releasing hormone and gonadotropin-releasing hormone (GnRH) neurons are located
[40]. Numerous in vitro and in vivo studies showed that the immune stress and the subsequent
action of proinflammatory cytokines have a profound impact on the secretory activity of GnRH
and LH neurons in the hypothalamus [41]. These interconnections between the immune and
the neuroendocrine systems are suggested to be based on the mutual sharing of receptors and
mediators.
As described above, staphylococcal infection either in peripheral or directly in vagina can
arouse strong immune/inflammatory reaction systematically or locally. The released cytokines
and chemokines then act on the pituitary gland and reproductive organs, which may finally
lead to menoxenia, irregular ovulation, and infertility. Evidences have shown that staphylo‐
coccal infection generates a large quantity of cytokines in female reproductive system. These
mediators have an important role in the control of reproductive neuroendocrine, ovarian
physiology, fetal implantation and development, and placenta function. Previous study
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revealed a correlation between BV, elevated IL-1β and IL-8, and idiopathic infertility, sug‐
gesting that abnormal vaginal flora and the vaginal inflammatory response may be responsible
for the idiopathic infertility in women undergoing in vitro fertilization [42].
5.2. Premature ovarian failure
Female mammals are born with a finite number of oocytes that gradually decreases during
prepubertal development and adult life [43]. Each oocyte is encircled by somatic granulosa
cells (GCs) to form the basic functioning unit of the ovary—the follicle. The size of the oocytes
at birth and the rate of endowment depletion dominate the ovarian functional lifespan. On the
other hand, programmed cell death (apoptosis) has been considered one of the most prevalent
mechanisms that contribute to the age-related exhaustion of oocytes. Therefore, a precise
balance has to be achieved between prosurvival and proapoptotic molecules to maintain the
final destiny of the follicle [44, 45].
It is well recognized that immune/inflammatory response participates in many aspects of
reproductive physiology, such as ovulation, menstruation, and implantation. Recent studies
suggest that the inflammatory stress caused by staphylococcal infection may also affect ovarian
reserve and cyclicity in women. Proinflammatory reaction, such as its correspondent neuro‐
transmitter secretion, inflammatory gene transcription, and signaling pathway activation, was
thought to play essential roles in the process. Moreover, the production of neurotransmitter,
such as sphingolipid ceramide, further acts as a second messenger to promote age-related
apoptosis of oocytes. Evidence showed that lower ceramide levels observed in acid sphingo‐
myelinase-deficient mice resulted in a larger postnatal pool of oocytes compared with their
wild-type counterparts. Conversely, Bax-null female mice exhibited to extend the ovarian
lifespan [46]. These data may provide novel perspectives on the regulation of oocyte dynamics
by bacterial infection and link the critical biological processes such as infection, inflammation,
cell survival, and female fertility.
5.3. Bacterial vaginosis and endometritis
BV is a polymicrobial syndrome mainly due to an imbalance of vaginal microbiota. Coloniza‐
tion and proliferation of staphylococci is supposed to be one of the reasons for the increase in
pathogenic bacteria, anaerobic bacteria, or microaerophiles. During the pathogenesis of BV,
the overgrowth of anaerobes promotes the production of noxious substances, such as polya‐
mines and other compounds. These metabolic products may further trigger the release of
proinflammatory cytokines IL-1β and IL-8 and thus cause tissue damage and physiological
imbalance [47]. BV can directly affect congenital formation and female fertility as an ascending
dissemination of the related bacteria species proved to cause tubal factor infertility.
Another complication accompanied by vaginal staphylococcal infection is chronic endome‐
tritis (CE), a local inflammatory disease characterized by unusual plasmacytic infiltration in
the endometrial stromal areas [48]. CE frequently happens in the later stage of the infection or
under repeated infection. It tends to be neglected in gynecologic practice because of its less
apparent symptom and the requirement of time-consuming histopathologic examinations. In
most cases, the diagnosis is made based on gynecological indications, such as abnormal uterine
bleeding (AUB) and infertility [49]. In a study on 64 CE patients and 28 healthy women, the
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biochemical analysis revealed that IL-6, IL-1β, and TNF-α levels were markedly higher in
menstrual effluents of women with CE when compared with control subjects [50]. It is
suggested that the infection and inflammation alter the endometrial cytokine profiles, which
may further impair endometrial function and lead to menstrual abnormalities and reduced
embryo receptivity [51]. Moreover, the proteomic analysis identified the key signaling
pathways involved in inflammation and oxidative stress are closely related with carcinoge‐
netic processes. These studies associate the onset of CE with female infertility, obstetric and
neonatal abnormity, and complications. The altered endometrial gene expression may explain
the impaired endometrial receptivity and endometrial hyperplastic lesions observed in women
affected by CE [52].
5.4. Abnormal fetal implantation
In rodents and humans, implantation is the first coordinated encounter between mother and
baby. The abnormal implantation and placentation may lead to various dysfunctions through‐
out the pregnancy. Pre-eclampsia (PE) is a pregnancy-induced disorder characterized by
hypertension and proteinuria. It is estimated to affect about 8% of pregnancies and is thought
to be unique to humans [53]. The etiology of PE still remains poorly understood, but abnormal
placentation is proved to be a major reason for this disease. In addition, local infection and
immune responses are critically involved in the process of implantation [54]. Increased
placental secretion of proinflammatory cytokines as well as the angiogenic regulators has been
implicated in the widespread maternal endothelial dysfunction and the development of PE. It
has been shown that cytokines produced within the uterine microenvironment can alter
trophoblast action [55], impair implantation, and placenta vascularization, which may account
for the recurrent miscarriage in women [56]. Elevated circulating IL-15 levels, proportional to
severity of diseases, have been detected in the serum of PE mothers when compared with
healthy controls [57]. Also, IL-11 is also proved to be a contributing factor for the impaired
trophoblast invasion, spiral artery remodeling, and altered placental labyrinth morphology.
These functional abnormities further lead to the development of PE-like features, such as
elevated systolic blood pressure (SBP), proteinuria, and kidney glomerular pathology. Another
proinflammatory cytokine, interferon (IFN)-γ, was also elevated in plasma, circulating
leukocytes, and decidua of patients with PE [58]. Besides this, decidual natural killer (dNK)
cells, the predominant immune cell, coincide with the decidualization at the maternal-fetal
interface in human and mice. All of these studies point to a critical role of immune/inflamma‐
tory response during the implanting and placental development. More importantly, vaginal
Staphylococcus infection, an infectious agent frequently observed in the uterus, may participate
in the development of implantation disorder presumably by the induction of local immune
reaction.
6. Therapy
Antibiotic strategy is considered the most potential therapeutic methods against staphylococ‐
cal infection and the resultant infertility. However, the emergence of antibiotic resistance has
dramatically increased in the past two decades and becomes a serious threat to the worldwide
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public health. According to the National Healthcare Safety Network (NHSN) and Centers for
Disease Control and Prevention, S. aureus and Enterococcus are the two most commonly
reported pathogens, accounting for 15.6% and 13.9% of health care–associated infections,
respectively. In particular, S. aureus is notorious for its ability to acquire the resistance to any
antibiotic during the treatment of infection-associated infertility.
6.1. Methicillin
The introduction of penicillin in the early 1940s significantly reduced fatal invasive staphylo‐
coccal infection. However, the resistant strains, mostly S. aureus strains, emerged rapidly.
These strains possess a plasmid-encoding enzyme, penicillinase, which can irreversibly
hydrolyze the β-lactam, thus acquiring the drug resistance. Methicillin is a narrow-spectrum
β-lactam antibiotic of the penicillin class. It can effectively block the synthesis of bacterial cell
walls by inhibiting the peptidic cross-linkage between the linear peptidoglycan polymer
chains. Therefore, the antibiotic destroys the integrity of the cell wall and selectively kills Gram-
positive bacteria. Compared with penicillin, methicillin harbors an orthodimethoxyphenyl
group attached to the side chain of the β-lactam, which, in turn, forms a steric effect to prevent
penicillinase from hydrolyzing the β-lactam. Even though, the first strain of MRSA, with an
altered PBP2a to reduced affinity for the β-lactam, was reported two years later [59]. Now,
MRSA refers to any strain of S. aureus that has developed resistance to β-lactam antibiotics
such as the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalospor‐
ins. Resistance is generally conferred by the acquisition of the mecA gene, which encodes a
PBP2a. Due to the significantly decreased affinity for β-lactams, MRSA strains restore the
ability of cell wall biosynthesis to continue even in the presence of typically inhibitory
concentrations of antibiotic [11].
6.2. Vancomycin
Vancomycin belongs to the glycopeptide antibiotic class and is effective in treatment of serious
infections caused by Staphylococcus. It is one of the main resources for combating infections
caused by MRSA but is not recommended to treat the disease caused by methicillin-sensitive
S. aureus (MSSA). Vancomycin is a complex compound consisting of a branched tricyclic
glycosylated peptide and is a rare example of a halo-organic natural compound containing
two covalently bonded chlorine atoms. The bactericidal activity of vancomycin is associated
with its ability to bind at the D-Ala-D-Ala dipeptide terminus of the nascent peptidoglycan in
Gram-positive bacteria and thereby to inhibit the peptidoglycan synthesis [60]. Common side
effects associated this antibiotic involve pain in the area of injection and allergic reactions, and
problems with hearing, low blood pressure, or bone marrow suppression occasionally occur.
The strain with the reduced susceptibility to vancomycin (VISA) was first described in 1996,
and the alteration of the D-Ala-D-Ala dipeptide was supposed to be the main reason under‐
lying this resistance.
6.3. Linezolid
Linezolid has been used for treatment of serious infections caused by Gram-positive bacteria
that are resistant to other antibiotics such as MRSA. Its spectrum of activity is similar to that
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of vancomycin, a well-established antibiotic for MRSA infections. Either linezolid or vanco‐
mycin has been recommended by the US guidelines as the first-line treatment for hospital-
acquired (nosocomial) MRSA pneumonia [61]. Mechanistically, linezolid binds to the 50s
subunit of the bacterial ribosome through interaction with the central loop of the 23S rRNA
and thus impedes the growth of bacteria by disrupting their production of proteins. Point
mutation of 23S rRNA is the most common mechanism of linezolid resistance [62]. The
common side effects of linezolid include diarrhea, headache, nausea, vomiting, rash, consti‐
pation, altered taste perception, and discoloration of the tongue, although they happen
relatively rarely.
6.4. Daptomycin
Daptomycin is the first cyclic lipopeptide approved for clinical use in 2003. It is a calcium-
dependent antibiotic comprising a lipid molecule conjugated with anionic peptide. Daptomy‐
cin interacts with the cytoplasmic membrane in a calcium-dependent, leading to the cell
membrane depolarization, ion loss, and cell death [63]. Many antibiotic-resistant strains, such
as MRSA and VRSA, were found to be effectively inhibited by daptomycin. Till 2008, the first
case of daptomycin resistance was reported, and the underlying mechanism is currently still
not very clear [64]. However, the mutation of the mprF gene, which encodes lysyl-phospha‐
tidyl glycerol (LPG) synthetase, might be related to the occurrence of resistant strains. LPG
can catalyze the coupling of lysine to PG and transfer the lysyl-PG to the outer leaflet of the
membrane. In this way, LPG increases the positive charge and thus reduces the binding of
Ca2+-bound daptomycin to bacterial membranes [65].
Besides the routinely used antibiotics mentioned above, numerous new antibiotics are
developed to serve as the alternatives in treating staphylococcal infection and the associated
infertility. For example, teicoplanin or quinupristin/dalfopristin has been widely used with
daptomycin to treat Gram-positive bacterial infection. Some of the potential antibiotics, such
as oritavancin and iclaprim, are currently in the early stages of clinical development, and other
promising candidates, such as ceftobiprole, dalbavancin, and telavancin, are still being
developed [66].
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